{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:41:23Z","timestamp":1788288083635,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.diagmicrobio.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T22:01:22Z","timestamp":1500588082000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp."],"prefix":"10.1016","volume":"89","author":[{"given":"Danielle","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bonifas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauretta","family":"Stapert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean L.","family":"Shinabarger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Pillar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","author":"Antinori","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0015","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/AAC.00160-09","article-title":"In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies","volume":"53","author":"Cant\u00f3n","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijantimicag.2014.06.007","article-title":"Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections","volume":"44","author":"Castanheira","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0030","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-a","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0035","series-title":"Approved standard\u2014Third edition. CLSI document M27-A3","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0040","series-title":"Fourth informational supplement. CLSI document M27-S4","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0045","doi-asserted-by":"crossref","first-page":"236903","DOI":"10.1155\/2013\/236903","article-title":"In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method","volume":"2013","author":"Eksi","year":"2013","journal-title":"ScientificWorldJournal"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0050","first-page":"3846","article-title":"In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob agents Chemother","volume":"46","author":"Ernst","year":"2002"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0055","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0060","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 6","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0070","article-title":"CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility","author":"Krishnan","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance","volume":"26","author":"Morgan","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0080","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JCM.42.8.3475-3482.2004","article-title":"Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species","volume":"42","author":"Odds","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.07.007_bb0085","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety and efficacy of CD101, a novel Echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0100","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/JCM.43.12.5848-5859.2005","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0105","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2014.03.004","article-title":"Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp","volume":"79","author":"Pfaller","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0115","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/jac\/dkw214","article-title":"Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates","volume":"71","author":"Pfaller","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JCM.41.3.1143-1146.2003","article-title":"Proficiency testing program for clinical laboratories performing antifungal susceptibility testing of pathogenic yeast species","volume":"41","author":"Ramani","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0125","first-page":"294","article-title":"Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital","volume":"42","author":"Skrodeniene","year":"2006","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/B:MYCO.0000020594.35357.b0","article-title":"Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia","volume":"157","author":"Sojakova","year":"2004","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2017.07.007_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317302237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317302237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T22:53:55Z","timestamp":1535583235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889317302237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0732889317302237"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.07.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}